A new therapy using non-thermal radio waves has been effective in blocking the growth of liver cancer cells anywhere in the body without deteriorating healthy cells. The study was conducted by the most excellent scholars in Wake Forest School of Medicine. The research aims to identify and locate the exact cascade within the tumor cells that will eventually lead to the anti-cancer effects.
With the use of animals as research models, the team delivered levels of radio frequencies to mice that were infected with human cancer cells to reproduce hepatocellular carcinoma or HCC. Hepatocellular relates to liver cells, while carcinoma is a malignant tumor that starts in the surface layer of an organ or body part and may spread to other parts of the body. HCC is known to be the most common type of liver cancer that affected humans since 1980.
Today, the use of radio frequencies delivered to patients with HCC in Europe proved to be effective in treating cancer cells. It is also in the same country where a device intended to cure HCC using radio frequencies has been permitted for medical purposes.
The research team headed by Boris Pasche, M.D, Ph.D., Chair of Cancer Biology and Director of the Comprehensive Cancer Center at Wake Forest Baptist explained the process of the study. They utilized a device, invented by Pasche and another scientist named Alexander Barbault in Germany. The said device is designed to deliver cancer-specific, amplitude-modulated radiofrequency electromagnetic fields (AM RF-EMF) programmed correctly for HCC patients. The AM RF EMF activated a calcium passage on the surface of HCC tumor cells but not on noncancerous cells, said Pasche.
A specific calcium channel was acting like an antenna for the radio signals that researchers sent out. The radio signals will then allow calcium to penetrate the HCC cell membrane and go directly inside the affected cells, removing the growth of cancer cells. “The study showed that the radiofrequency delivered was at low and safe levels,” Pasche said. It was smaller than those generated by holding a cell phone close to the ear.
How can this device effectively cure cancer cells in the liver?
It has come to the researchers that it was the entry of calcium that stopped the growth of HCC cells and even shrunk it. In some cases, it miraculously eliminated the tumors spreading around the liver part, with the help of the said frequency device. The effect was similar when cancer had metastasized in other parts of the body; a positive indication that the tool can be helpful in the decade-long battle against cancer.
The device is licensed to TheraBionic Inc., formerly referred to as TheraBionic LCC and GmBH. It has been approved by the European Notified Body, the equivalent of the Food and Drug Administration or (FDA)in the United States. However, the device needs the approval of the FDA and is currently under evaluation before it reaches the U.S grounds.
Today, the treatment is viral in Europe and gained the public’s attention after regulators approved the device for patients with HCC. Consisting of a hand-held device about the size of a VHS tape cassette, it emits radio frequencies via a spoon-shaped element that is usually placed on the patient’s tongue. The patient can undergo treatment in the comfort of their homes three times a day for one hour only. As per Pasche, who happens to hold stock in TheraBionic Inc., the frequencies used are specific to the patient’s type of cancer as identified thru tumor biopsies or blood work.
Meanwhile, a separate study by Wake Forest Baptist researchers using the same technology in breast cancer cells was also published in the May 31 edition of EBioMedicine. Pasche and Barbault, as the primary authors of this study, have also discovered radio frequencies for 15 different types of cancer. The outcome was previously reported and published in 2009 in the Journal of Experimental and Clinical Cancer Research.